ES548617A0 - Procedimiento para disociar peptidos y proteinas en el enla-ce metionilo - Google Patents

Procedimiento para disociar peptidos y proteinas en el enla-ce metionilo

Info

Publication number
ES548617A0
ES548617A0 ES548617A ES548617A ES548617A0 ES 548617 A0 ES548617 A0 ES 548617A0 ES 548617 A ES548617 A ES 548617A ES 548617 A ES548617 A ES 548617A ES 548617 A0 ES548617 A0 ES 548617A0
Authority
ES
Spain
Prior art keywords
peptides
proteins
metionilo
enla
discount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES548617A
Other languages
English (en)
Other versions
ES8701780A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES8701780A1 publication Critical patent/ES8701780A1/es
Publication of ES548617A0 publication Critical patent/ES548617A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • C07K1/126—Aminolysis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES548617A 1984-11-09 1985-11-07 Procedimiento para disociar peptidos y proteinas en el enla-ce metionilo Expired ES8701780A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843440988 DE3440988A1 (de) 1984-11-09 1984-11-09 Verfahren zur spaltung von peptiden und proteinen an der methionyl-bindung

Publications (2)

Publication Number Publication Date
ES8701780A1 ES8701780A1 (es) 1986-12-01
ES548617A0 true ES548617A0 (es) 1986-12-01

Family

ID=6249917

Family Applications (1)

Application Number Title Priority Date Filing Date
ES548617A Expired ES8701780A1 (es) 1984-11-09 1985-11-07 Procedimiento para disociar peptidos y proteinas en el enla-ce metionilo

Country Status (15)

Country Link
US (1) US4644057A (es)
EP (1) EP0180920B1 (es)
JP (1) JPH0714960B2 (es)
KR (1) KR930007428B1 (es)
AT (1) ATE71109T1 (es)
AU (1) AU580348B2 (es)
CA (1) CA1247081A (es)
DE (2) DE3440988A1 (es)
DK (1) DK166546C (es)
ES (1) ES8701780A1 (es)
FI (1) FI85494C (es)
GR (1) GR852693B (es)
IE (1) IE58683B1 (es)
PT (1) PT81445B (es)
ZA (1) ZA858603B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4745178A (en) * 1987-04-22 1988-05-17 Eli Lilly And Company Process for selective peptide bond cleavage using sulfoxides and CF3 CO
DE3726655A1 (de) * 1987-08-11 1989-02-23 Hoechst Ag Verfahren zur isolierung basischer proteine aus proteingemischen, welche solche basischen proteine enthalten
US4945157A (en) * 1988-05-27 1990-07-31 University Of Florida Novel Extraction procedure for protein G
CZ283234B6 (cs) * 1990-09-05 1998-02-18 Hoechst Aktiengesellschaft Enymatický způsob konverse preproinsulinů na insuliny
DE59711533D1 (de) 1996-07-26 2004-05-27 Aventis Pharma Gmbh Insulinderivate mit erhöhter Zinkbindung
DE19726167B4 (de) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
US7193035B2 (en) * 2002-10-29 2007-03-20 Sanofi-Aventis Deutschland Gmbh Crystals of insulin analogs and processes for their preparation
KR20110059602A (ko) 2008-08-07 2011-06-02 바이오콘 리미티드 인슐린 화합물의 제조방법
PT3228320T (pt) 2008-10-17 2020-03-26 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
KR101853606B1 (ko) 2009-07-06 2018-05-03 사노피-아벤티스 도이칠란트 게엠베하 메티오닌을 함유하는 수성 인슐린 제제
DK2498802T3 (en) 2009-11-13 2015-04-13 Sanofi Aventis Deutschland Pharmaceutical composition comprising a GLP-1 agonist, insulin and a methionine
KR101337322B1 (ko) 2009-11-13 2013-12-06 사노피-아벤티스 도이칠란트 게엠베하 Ｇｌｐ-1 효능제 및 메티오닌을 포함하는 약제학적 조성물
ES2606554T3 (es) 2010-08-30 2017-03-24 Sanofi-Aventis Deutschland Gmbh Uso de AVE0010 para la fabricación de un medicamento para el tratamiento de la diabetes mellitus de tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
PL2750699T3 (pl) 2011-08-29 2015-12-31 Sanofi Aventis Deutschland Kombinacja farmaceutyczna do stosowania w kontroli glikemii u pacjentów z cukrzycą typu 2
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
AU2015359376B2 (en) 2014-12-12 2021-09-09 Sanofi-Aventis Deutschland Gmbh Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE337223B (es) * 1967-05-23 1971-08-02 Pharmacia Ab
US3935072A (en) * 1972-08-10 1976-01-27 Tanabe Seiyaku Co., Ltd. Purification of coenzyme A
US3876501A (en) * 1973-05-17 1975-04-08 Baxter Laboratories Inc Binding enzymes to activated water-soluble carbohydrates
US3919049A (en) * 1974-06-27 1975-11-11 Tokyo Tanabe Co Process for preparing {62 -galactosidase
SE8302758L (sv) * 1983-05-17 1984-11-18 Pharmacia Ab Sett for uppspjelkning av disulfidbindningar och derigenom erhallen forening
GB8317697D0 (en) * 1983-06-29 1983-08-03 Shell Int Research Dissolution of peptides in non-aqueous and mixed non-aqueous/aqueous solvents
US4496689A (en) * 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer

Also Published As

Publication number Publication date
ZA858603B (en) 1986-07-30
GR852693B (es) 1986-03-10
FI85494C (fi) 1992-04-27
ATE71109T1 (de) 1992-01-15
AU4971385A (en) 1986-05-15
IE852795L (en) 1986-05-09
US4644057A (en) 1987-02-17
EP0180920A2 (de) 1986-05-14
KR930007428B1 (ko) 1993-08-10
EP0180920A3 (en) 1989-01-04
ES8701780A1 (es) 1986-12-01
DK516485A (da) 1986-05-10
JPS61115096A (ja) 1986-06-02
FI854383A0 (fi) 1985-11-07
DK166546B (da) 1993-06-07
PT81445B (pt) 1987-12-30
KR860003832A (ko) 1986-06-13
PT81445A (de) 1985-12-01
AU580348B2 (en) 1989-01-12
JPH0714960B2 (ja) 1995-02-22
DK166546C (da) 1993-10-25
EP0180920B1 (de) 1992-01-02
DK516485D0 (da) 1985-11-08
FI85494B (fi) 1992-01-15
CA1247081A (en) 1988-12-20
DE3585078D1 (de) 1992-02-13
DE3440988A1 (de) 1986-07-10
IE58683B1 (en) 1993-11-03
FI854383L (fi) 1986-05-10

Similar Documents

Publication Publication Date Title
FI854383A0 (fi) Foerfarande foer avspaltning av peptider och proteiner av metionyl-bindning.
DK0477971T3 (da) Humant CNP gen og precursorprotein
PT89961A (pt) Processo para a preparacao de n-carboxianidridos de aminoacidos protegidos por uretano
FI864427A7 (fi) Menetelmä polypeptidin valmistamiseksi, joka on komplementaarinen ainakin osalle alkuperäistä peptidiä tai proteiinia, ja komplementaarisen polypeptidin käyttö
ES2073571T3 (es) Aplicacion de nuevos fragmentos de adn como secuencia que codifica un peptido señal para la secrecion de proteinas maduras, mediante levaduras recombinantes, cassettes de expresion, levaduras transformadas y procedimiento correspondiente de preparacion de proteinas.
ATE78042T1 (de) Analoge des humanen relaxins.
DK143492A (da) Human-h2-praeprorelaxin, -prorelaxin og -relaxin samt polypeptid med relaxinaktivitet
ES536027A0 (es) Un procedimiento para la produccion de un polipeptido
IT8319160A0 (it) Procedimento di sintesi di peptidi e agenti di bloccaggio di amminoacidi.
FI851508A7 (fi) Syklopropaaniaminohappojen ja peptidien synteesi.
DK403384D0 (da) Enteralt effektivt, biologisk aktivt peptid- eller proteinmiddel ogfremgangsmaader til fremstilling deraf
DK383985A (da) Polypeptid
DK354389D0 (da) Polypeptid
ATE115409T1 (de) Glykoprotein-hormonrezeptor-moleküle.
IT1215973B (it) Analoghi della ammino prostaglandina 7 ossabicicloeptansostituiti.
ES2078229T3 (es) Procedimiento para la preparacion de un polipeptido similar a la motilina y su expresion.
FI943218L (fi) Kaseinomakropeptidin peptidit, mainittujen peptidien vasta-aineet ja käytöt
DE3873273D1 (de) Verfahren zur selektiven spaltung von fusionsproteinen.
FI942392A0 (fi) Peptidejä ja vasta-aineita nivelreuman hoitoon
IT8419957A0 (it) Processo per la sintesi di amminoacidi e in particolare di alfa-fenil-glicina.
DK369888A (da) Peptidforbindelser